BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ardelyx Inc. 

34175 Ardenwood Boulevard
Suite 100
Fremont  California  94555  U.S.A.
Phone: 510-745-1700 Fax: n/a


SEARCH JOBS










 Company News
Ardelyx Inc. (ARDX) Appoints Jeremy S. Caldwell, Ph.D., As Executive Vice President And Chief Scientific Officer 12/1/2014 4:02:58 PM
Ardelyx Inc. (ARDX)'s Tenapanor Reduces Phosphorus Absorption And Protects Against Vascular Calcification In Preclinical In Vivo Model Of Chronic Kidney Disease 11/17/2014 3:26:38 PM
Ardelyx Inc. (ARDX) Reports Third Quarter 2014 Financial Results 11/6/2014 8:57:39 AM
Ardelyx Inc. (ARDX) To Report Third Quarter 2014 Financial Results On November 6, 2014 10/30/2014 9:36:19 AM
Ardelyx Inc. (ARDX)'s Tenapanor Selected For Oral And Poster Presentations At The American Society of Nephrology's Kidney Week 2014 10/23/2014 11:04:58 AM
Ardelyx Inc. (ARDX) Looks Good After Tenanpanor Results: Citi Analysts 10/1/2014 3:14:37 PM
Ardelyx Inc. (ARDX) Irritable Bowel Syndrome Drug Succeeds In Phase 2b Trial 10/1/2014 6:01:51 AM
Ardelyx Inc. (ARDX) Chief Scientific Officer, Dominique Charmot, Announces Retirement From The Company At Year-End 9/5/2014 9:50:39 AM
Ardelyx Inc. (ARDX) To Present At The Wedbush 2014 Life Sciences Management Access Conference 8/5/2014 9:31:07 AM
Ardelyx Inc. (ARDX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/25/2014 6:20:40 AM
12